Prothea Technologies

Series-A
prothea.tech Biotech & Healthcare
Total Funding $13M
Latest Round Undisclosed Series-A
Last Announced Apr 25, 2025
Investors Undisclosed
Decision Makers 2 Verified

About Prothea Technologies

The biopsy and treatment of lung cancer in a single hospital visit – reducing time-to-treat from weeks to minutes; relieving hospital pressures, improving patient outcomes.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website prothea.tech
Domain Registered Date Jan 3, 2024

Social & Network Presence

X / Twitter Profile @ProtheaTech (5 followers) Created on Apr 2024
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Series-A announced

    startupintros.com

  2. Milestone

    X account created (@ProtheaTech)

    5 followers

  3. Capital Raise

    Raised $13,000,000 · Series-A

    startupintros.com

  4. Milestone

    Website domain registered

    prothea.tech

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Prothea Technologies.

Funding History

2 Rounds
Series-A · Apr 25, 2025
Series-A · Apr 1, 2024

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts